[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

IS8612A - Stable statin formulations - Google Patents

Stable statin formulations

Info

Publication number
IS8612A
IS8612A IS8612A IS8612A IS8612A IS 8612 A IS8612 A IS 8612A IS 8612 A IS8612 A IS 8612A IS 8612 A IS8612 A IS 8612A IS 8612 A IS8612 A IS 8612A
Authority
IS
Iceland
Prior art keywords
stable statin
statin formulations
formulations
stable
statin
Prior art date
Application number
IS8612A
Other languages
Icelandic (is)
Inventor
Jóhannsson Fjalar
Original Assignee
Actavis Group Ptc Ehf.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Actavis Group Ptc Ehf. filed Critical Actavis Group Ptc Ehf.
Priority to IS8612A priority Critical patent/IS8612A/en
Priority to PCT/IS2008/000006 priority patent/WO2008102379A1/en
Priority to EP08710292A priority patent/EP2124904A1/en
Publication of IS8612A publication Critical patent/IS8612A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
IS8612A 2007-02-19 2007-02-19 Stable statin formulations IS8612A (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
IS8612A IS8612A (en) 2007-02-19 2007-02-19 Stable statin formulations
PCT/IS2008/000006 WO2008102379A1 (en) 2007-02-19 2008-02-19 Stable sustained release formulations of fluvastatin
EP08710292A EP2124904A1 (en) 2007-02-19 2008-02-19 Stable sustained release formulations of fluvastatin

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IS8612A IS8612A (en) 2007-02-19 2007-02-19 Stable statin formulations

Publications (1)

Publication Number Publication Date
IS8612A true IS8612A (en) 2008-08-20

Family

ID=39523591

Family Applications (1)

Application Number Title Priority Date Filing Date
IS8612A IS8612A (en) 2007-02-19 2007-02-19 Stable statin formulations

Country Status (3)

Country Link
EP (1) EP2124904A1 (en)
IS (1) IS8612A (en)
WO (1) WO2008102379A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104069502B (en) * 2013-03-29 2018-02-16 北京罗诺强施医药技术研发中心有限公司 Compound skeleton material and its pharmaceutical composition

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9603667D0 (en) * 1996-10-08 1996-10-08 Astra Ab Pharmaceutical compositions
US20010006644A1 (en) * 1997-07-31 2001-07-05 David J. Bova Combinations of hmg-coa reductase inhibitors and nicotinic acid and methods for treating hyperlipidemia once a day at night
WO2005058310A2 (en) * 2003-12-16 2005-06-30 Novartis Ag Use of stating for the treatment of metabolic syndrome
KR100598326B1 (en) * 2004-04-10 2006-07-10 한미약품 주식회사 EXTENDED RELEASE ORAL FORMULATION OF HMG-CoA REDUCTASE INHIBITOR AND METHOD FOR THE PREPARATION THEREOF

Also Published As

Publication number Publication date
EP2124904A1 (en) 2009-12-02
WO2008102379A1 (en) 2008-08-28

Similar Documents

Publication Publication Date Title
NO2021010I1 (en) telostritate ethyl
LTPA2018005I1 (en) Pharmaceutical composition
BRPI0820381A2 (en) Pharmaceutical Formulations
DK2068886T3 (en) Lipid-containing preparations
BRPI0814188A2 (en) FORMULATIONS
BRPI0814252A2 (en) Antibody Formulations
BRPI0814003A2 (en) ANTIBODY FORMULATIONS
DK2066354T3 (en) Norovirus vaccine formulations
BRPI0908785A2 (en) Herbicide Formulations
BRPI0721651A2 (en) PHARMACEUTICAL COMPOSITION
NO20075628L (en) Pharmaceutical formulations
RU2493831C3 (en) PHARMACEUTICAL COMPOSITIONS
BRPI0821831A2 (en) Insecticide Compounds
BRPI0807453A2 (en) SOLID PREPARATION
DK3354267T3 (en) STABILIZED SULFORAPHAN
DK2114143T3 (en) LIQUID SULPHONYLUREA HERBICID FORMULATIONS
DK2120884T3 (en) Pharmaceutical composition
DK2966175T3 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING CORTEXOLON-17-ALPHA-PROPIONATE
DE602007007755D1 (en) footplate
BRPI0820198A2 (en) pharmaceutical compositions
BRPI0817053A2 (en) Orlistat Pharmaceutical Formulations
FR2896414B1 (en) MATIFYING COSMETIC COMPOSITION
BRPI0809653A2 (en) MANOPROTEIN NET FORMULATIONS
FR2915896B1 (en) COSMETIC COMPOSITION FOISONNEE
FR2924022B1 (en) COSMETIC COMPOSITION TENSEUR